Trump HHS pick faces calls for probe of stock trades
WASHINGTON - President-elect Donald Trump's nominee to be the nation's top health official is facing calls for investigation of whether his stock picks were guided by insider knowledge as a senior member of Congress.
Georgia Republican congressman Tom Price was chosen by Trump partly for of his plan to repeal "Obamacare." His confirmation hearings are expected to be a spirited debate about the future of federal health insurance programs.
Now the hearings could veer in a different direction, involving legal and ethical questions.
The Trump transition team says Price has complied fully with all applicable laws and ethics rules and that Democrats are playing politics.
A senior Democratic lawmaker - congresswoman Louise Slaughter of New York - and the advocacy group Public Citizen have asked the Securities and Exchange Commission to investigate.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
State officials push African-American community to get vaccinated in Ascension Parish
BRG to receive largest Pfizer vaccine shipment this week
Firefighters battle blazing house fire on Terrace Avenue
State wrestling tournament gives downtown BR a boost in business
FDA approves emergency use of single-shot COVID vaccine from Johnson & Johnson